Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
How We Provide GHK-Cu at Intra-V We make this advanced therapy easy and accessible: Pharmaceutical-grade GHK-Cu shipped directly to your home Administered as a daily or 5x weekly subcutaneous injection
elevated triglycerides (defined as 150 mg/dL), decreased High Density Lipoprotein (HDL) (ranges below 40 mg/dL in men and 50 mg/dL in women), elevated blood pressure (defined as systolic blood pressure above 130 mmHg or diastolic blood pressure above 85 mmHg) and elevated fasting glucose (defined as blood glucose above 100 mg/dL)
PMID: 16965771
The Fundamental Divide: Two Completely Different Mechanisms The three compounds split into two mechanistic families: Family 1 Growth-hormone fragment (direct lipolysis): AOD-9604 acts directly on adipose tissue, studied for stimulating lipolysis and inhibiting lipogenesis, independent of the IGF-1 receptor
